NIKKEI 225
38,079.70 +117.90 (+0.31%) HANG SENG
16,385.87 +134.03 (+0.82%) CRUDE OIL
83.25 +0.56 (+0.68%) GOLD FUTURES
2,402.20 +13.80 (+0.58%) DOW
37,795.94 +42.63 (+0.11%) Bitcoin GBP
51,083.27 +2,562.98 (+5.28%)
Aspira Women's Health Inc. (AWH)
| Previous close | 3.4900 |
| Open | 3.5600 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 3.4012 - 3.5600 |
| 52-week range | 2.3100 - 6.7500 |
| Volume | |
| Avg. volume | 31,496 |
| Market cap | 41.985M |
| Beta (5Y monthly) | 1.61 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.8100 |
| Earnings date | 09 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 5.25 |
GlobeNewswireAspira Women’s Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California
Coverage represents approximately 6 million lives, including commercial, Medicare Advantage, and MedicaidAUSTIN, Texas, April 09, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced a new agreement with Anthem Blue Cross in California for reimbursement coverage of the Company’s OvaSuiteSM portfolio of risk assessment tests ef
- GlobeNewswire
Aspira Women’s Health Reports Fourth Quarter and Full Year 2023 Financial Results
2023 OvaSuite revenue of $9.2 million, an increase of 15% year-over-year 2023 OvaSuite volume of 23,990 units, an increase of 12% year-over-year Cash utilization declined in both the fourth quarter and full-year 2023 to $3.5 million and $15.9 million, respectively Conference Call and Webcast scheduled for today at 8:30 am ET AUSTIN, Texas, March 28, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused
- GlobeNewswire
Aspira Women’s Health Announces New Time for its Fourth Quarter and 2023 Year End Earnings Results and Call
Management to Announce Earnings Results on Thursday, March 28, and hold a call at 8:30 am ETAUSTIN, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that the Company will report its financial results for the three months and year ended December 31, 2023, on Thursday, March 28, 2024. Management will also ho
